Ligands of peroxisome proliferator-activated receptor-γ increase the generation of vascular endothelial growth factor in vascular smooth muscle cells and in macrophages

Acta Biochimica Polonica

Volumn 47, Issue 4, 2000, Pages 1147-1157

  Jozkowicz, Alicja ^a,c   Dulak, Jozef ^b   Piatkowska, Ewa ^a   Placha, Wojciech ^a   Dembinska Kiec, Aldona ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Angiogenesis; Ciglitazone; Peroxisome proliferator activated receptor ; Prostaglandin j2; Thiazolidinediones; Vascular endothelial growth factor

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 9-DEOXY-DELTA-9-PROSTAGLANDIN D2; ANTIDIABETIC AGENT; ANTINEOPLASTIC AGENT; CELL RECEPTOR; CIGLITAZONE; DRUG DERIVATIVE; ENDOTHELIAL CELL GROWTH FACTOR; INTERLEUKIN 1; LIGAND; LIPOPOLYSACCHARIDE; LYMPHOKINE; MESSENGER RNA; PROSTAGLANDIN D2; PROSTAGLANDIN J2; THIAZOLE DERIVATIVE; TRANSCRIPTION FACTOR; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL; ARTICLE; CELL CULTURE; CELL LINE; CYTOLOGY; DOSE RESPONSE; GENETIC TRANSFECTION; MACROPHAGE; METABOLISM; MOUSE; PROMOTER REGION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE; TRANSACTIVATION; UPREGULATION; VASCULAR ENDOTHELIUM;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; HYPOGLYCEMIC AGENTS; INTERLEUKIN-1; LIGANDS; LIPOPOLYSACCHARIDES; LYMPHOKINES; MACROPHAGES; MICE; MUSCLE, SMOOTH; PROMOTER REGIONS (GENETICS); PROSTAGLANDIN D2; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THIAZOLES; THIAZOLIDINEDIONES; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSFECTION; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034585795     PISSN: 0001527X     EISSN: None     Source Type: Journal    
DOI: 10.18388/abp.2000_3967     Document Type: Article

References (52)

1. Michalik, L. & Wahli, W. (1999) Peroxisome proliferator-activated receptors: Three isotypes for a multitude of functions. Curr. Opin. Biotechnol. 10, 564-570.
2. Motojima, K., Passilly, P., Peters, J.M. & Gonzales, F.J. (1998) Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue-and inducer-specific manner. J. Biol. Chem. 273, 16710-16714.
3. Tontonoz, P., Hu, E., Devine, J., Beale, E.G. & Spiegelman, B.M. (1995) PPARγ2 regulates adipose expression of phosphoenolopyruvate carboxykinase gene. Mol. Cell Biol. 15, 351-357.
4. Schoonjans, K., Watanabe, M., Suzuki, H., Mahfoudi, A., Krey, G., Wahli, W., Grimaldi, P., Staels, B., Yamamoto, T. & Auwerx, J. (1995) Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter. J. Biol. Chem. 270, 19269-19276.
5. Rodriquez, J.C., Gil-Gomez, G., Hegardt, F.G. & Haro, D. (1994) Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. J. Biol. Chem. 269, 18767-18772.
6. Ribon, V., Johnson, J.H., Camp, H.S. & Saltiel, A.R. (1998) Thiazolidinediones and insulin resistance: Peroxisome proliferator-activated receptor gamma activation stimulates the expression of CAP gene. Proc. Natl. Acad. Sci. U.S.A. 95, 14751-14756.
7. Elstner, E., Muller, C., Koshizuka, K., Wiliamson, E.A., Park, D., Asou, H., Shintaku, P., Said, J.W., Heber, D. & Koeffler, H.P. (1998) Ligands for peroxisome proliferator-activated receptor gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc. Natl. Acad. Sci. U.S.A. 95, 8806-8811.
8. Kubota, T., Koshizuka, K., Williamson, E.A., Asou, H., Said, J.W., Holden, S., Miyoshi, I. & Foeffler, H.P. (1998) Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res. 58, 3344-3352.
9. Sarraf, P., Mueller, E., Jones, D., King, F.J., De Angelo, D.J., Partridge, J.B., Holden, S.A., Chen, L.B., Singer, S., Fletcher, C. & Spiegelman, B.M. (1998) Differentiation and reversal of malignant changes in colon cancer through PPARγ. Nature Med. 4, 1046-1052.
10. Yoshimoto, T., Naruse, M., Shizume, H., Naruse, K., Tanabe, A., Tanaka, M., Tago, K., Irie, K., Muraki, T., Demura, H. & Zardi, L. (1999) Vasculo-protective effects of insulin sensitizing agent pioglitazone in neointimal thickening and hypertensive vascular hypertrophy. Atherosclerosis 145, 333-340.
11. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nature Med. 1, 27-31.
12. Schaper, W. & Buschmann, I. (1999) VEGF and therapeutic opportunities in cardiovascular diseases. Curr. Opin. Biotechnol. 10, 541-543.
13. Adamis, A.P., Miller, J.W., Bernal, M.T., D'Amico, D.J., Yeo, T.K. & Yeo, K.T. (1994) Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative retinopathy. Am. J. Ophthalmol. 118, 445-450.
14. Aiello, L.P., Avery, R.L., Arring, P.G., Keyt, B.A., Jampel, H.D., Shah, S.T., Pasquale, L.R., Thieme, H., Iwamoto, M.A., Park, J.E., Nguyen, M.S., Aiello, L.M., Ferrara, N. & King, G.L. (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other disorders. N. Engl. J. Med. 331, 1480-1487.
15. Malecaze, F., Favard, C., Simorre-Pinatel, V., Mathis, A., Chollet, P., Favard, C., Bayard, F. & Plouet, J. (1994) Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch. Ophthal. 112, 1476-1482.
16. Pe'er, J., Shweiki, D., Itin, A., Hemo, I., Gnessin, H. & Keshet, E. (1995) Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab. Invest. 72, 638-645.
17. Aiello, L.P., Pierce, E.A., Foley, E.D., Takagi, H., Chen, H., Riddle, L., Ferrara, N., King, G.L. & Smith, L.E.H. (1995) Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc. Natl. Acad. Sci. U.S.A. 92, 10457-10461.
18. Robinson, G.S., Pierce, E.A., Rook, S.L., Foley, E., Webb, R. & Smith, L.E.S. (1996) Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc. Natl. Acad. Sci. U.S.A. 93, 4851-4856.
19. Adamis, A.P., Shima, D.T., Tolentino, M.J., Gragoudas, E.S., Ferrara, N., Folkman, J., D'Amore, P.A. & Miller, J.W. (1996) Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization. Arch. Ophthalmol. 114, 66-71.
20. Okamoto, N., Tobe, T., Hackett, S.F., Ozaki, H., Vinores, M., LaRochelle, W., Zack, D.J. & Campochiaro, P.A. (1997) Transgenic mice with increased expression of vascular endothelial growth factor in the retina. A new model of intraretinal and subretinal neovascularization. Am. J. Pathol. 151, 281-291.
21. Xin, X., Suya, Y., Kowalski, J. & Gerristen, M.E. (1999) Peroxisome proliferator-activated receptor-γ ligands are potent inhibitors of angiogenesis in vitro and in vivo. J. Biol. Chem. 274, 916-921.
22. Bishop-Bailey, D. & Hla, T. (1999) Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-delta12, 14-prostaglandin J2. J. Biol. Chem. 274, 17042-17048.
23. Chomczynski, P. & Sacchi, N. (1987) Single step method of RNA isolation by acid guanidinum thiocyanate-phenol-chlorophorm extraction. Anal. Biochem. 162, 156-159.
24. Yu, K., Bayona, W., Kallens, C.B., Harding, H.P., Ravera, C.P., McMahon, G., Brown, M., & Lazar, M.A. (1995) Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem. 270, 23975-23983.
25. Yamakawa, K., Hosoi, M., Koyama, H., Tanaka, S., Fukumoto, S., Morii, H., & Nishizawa, Y. (2000) Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cell. Biochem. Biophys. Res. Commun. 271, 571-574.
26. Bamba, H., Ota, S., Kato, A., Kawamoto, C., Fujiwara, K. (2000) Prostaglandins up-regulate vascular endothelial growth factor production through distinct pathways in differentiated U937 cells. Biochem. Biophys. Res. Commun. 273, 485-491.
27. Tontonoz, P., Nagy, L., Alvarez, J.G., Thomazy, V.A., Evans, R.M. (1998) PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93, 241-252.
28. Ricote, M., Huang, J., Fajas, L., Li, A., Welch, J., Najib, J., Witzum, J.L., Auwerx, J., Palinski, W. & Glass, C.K. (1998) Expression of the peroxisome proliferator-activated receptor gamma (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized LDL. Proc. Natl. Acad. Sci. U.S.A. 95, 7614-7619.
29. Steals, B., Koenig, W., Habib, A., Merval, R., Lebret, M., Torra, I.P., Delerive, P., Fadel, A., Chinetti, G., Fruchard, J.C., Najib, J., Maclouf, J. & Tedgui, A. (1998) Activation of human aortic smooth muscle cells is inhibited by PPARα but not by PPARγ activators. Nature 393, 790-793.
30. Iijima, K., Yoshizumi, M., Ako, J., Eto, M., Kim, S., Hashimoto, M., Sugimoto, N., Liang, Y.Q., Sudoh, N., Toba, K. & Ouchi, Y. (1998) Expression of peroxisome proliferator-activated receptor-γ (PPARγ) in rat aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 247, 353-356.
31. Pasceri, V., Wu, H.D., Willerson, J.T. & Yeh, E.T.H. (2000) Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-γ activator. Circulation 101, 235-240.
32. Ricote, M., Li, A.C., Willson, T.M., Kelly, C.J. & Glass, C.K. (1998) The peroxisome proliferator-activated receptor gamma is a negative regulator of macrophage activation. Nature 391, 79-82.
33. Jiang, C., Ting, A.T. & Seed, B. (1998) PPARγ agonists inhibit production of monocyte inflammatory cytokines. Nature 391, 82-86.
34. Momoi, A., Murao, K., Imachi, H., Yoshitaka, S., Nakamura, H., Hosokawa, H., Sato, M., Fujita, J., Okada, H., Ishida, T. & Takahara, J. (1999) Thiazolidinedione inhibits production of RANTES in cytokine-treated human lung epithelial cell line. FEBS Lett. 452, 301-304.
35. Murao, K., Imachi, H., Atsuko, M., Sayo, Y., Hosokawa, H., Sato, M., Ishida, T. & Takahara, J. (1999) Thiazolidinedione inhibits the production of monocyte chemoattractant protein-1 in cytokine-treated human vascular endothelial cells. FEBS Lett. 454, 27-30.
36. Law, R.E., Meehan, W.P., Xi, X.P., Graf, K., Wuthrich, D.A., Coats, W., Faxon, D. & Hsueh, W.A. (1996) Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. J. Clin. Invest. 98, 1897-1905.
37. Kihara, S., Ouchi, N., Funahashi, T., Shinohara, E., Tamura, R., Yamashita, S. & Matsuzawa, Y. (1998) Troglitazone enhances glucose uptake and inhibits mitogen-activated protein kinase in human aortic smooth muscle cells. Atherosclerosis 136, 163-168.
38. Papapetropoulos, A., Garcia-Cardena, G., Madri, J.A. & Sessa, W.C. (1997) Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J. Clin. Invest. 100, 3131-3139.
39. Parenti, A., Mordibelli, L., Cui, X.L., Douglas, J.G., Hood, J.D., Granger, H.J., Ledda, F. & Ziehe, M. (1998) Nitric oxide is a upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase-1/ 2 activation in postcapillary endothelium. J. Biol. Chem. 273, 4220-4226.
40. Satoh, H., Tsukamoto, K., Hashimoto, Y., Hashimoto, N., Togo, M., Hara, M., Maekawa, H., Isoo, N., Kimura, S. & Watanabe, T. (1999) Thiazolidinediones suppress endothelin-1 secretion from bovine endothelial cells: A new possible role of PPARγ on vascular endothelial function. Biochem. Biophys. Res. Commun. 254, 757-763.
41. Delerive, P., Martin-Nizard, F., Chinetti, G., Trottein, F., Fruchard, J.C., Najib, J., Duriez, P. & Steals, B. (1999) Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway. Circ. Res. 85, 394-402.
42. Aiello, L.P. (1997) Vascular endothelial growth factor and the eye: Biochemical mechanisms of action and implications for novel therapies. Ophthalmic Res. 29, 345-362.
43. Hammes, H.P., Lin, J., Bretzel, R.G., Brownie, M. & Breier, G. (1998) Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes 47, 401-406.
44. Kimura, H., Weisz, A., Karashima, Y., Hashimoto, K., Ogura, T., D'Acqusto, F., Addeo, R., Makuchi, M. & Esumi, H. (2000) Hypoxia reponse element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: Control of hypoxia - inducible factor-1 activity by nitric oxide. Blood 95, 189-197.
45. Finkenzeller, G., Sparacio, A., Technau, A., Marme, D. & Siemeister, G. (1997) SP1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet derived growth factor-induced gene expression. Oncogene 15, 669-676.
46. Ryuto, M., Ono, M., Izumi, H., Yoshida, S., Weich, H.A., Kohna, K. & Kuwano, M. (1996) Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J. Biol. Chem. 271, 28220-28228.
47. Krey, G., Mahfoudi, A. & Wahli, W. (1995) Functional interactions of peroxisome proliferator-activated receptor, retinoid X-receptor, and SP1 in the transcriptional regulation of the acyl-coenzyme A oxidase promoter. Mol. Endocrinol. 9, 19-31.
48. Missbach, M., Jagher, B., Siga, I., Nayeri, S., Carlberg, C. & Wiesenberg, I. (1996) Thiazolidine diones specific ligands of the nuclear receptor retinoid Z receptor/retinoid acid receptor-related orphan receptor alpha with potent antiarthritic activity. J. Biol. Chem. 271, 13515-13522.
49. Winrow, C.J., Capone, J.P. & Rachubinski, R.A. (1998) Cross-talk between orphan nuclear hormone receptor RZRa and peroxisome activated-receptor alpha in regulation of the peroxisome hydratase-dehydrogenase gene. J. Biol. Chem. 273, 31442-31448.
50. Kitamura, Y., Kakimura, J., Matsuoka, Y., Nomura, Y., Gebicke-Haerter, P.J. & Taniguchi, T. (1999) Activators of peroxisome proliferator-activated receptor-γ (PPARγ) inhibit inducible nitric oxide synthase expression but increase heme oxygenase-1 expression in rat glial cells. Neurosci. Lett. 262, 129-132.
51. Jozkowicz, A., Placha, W., Krzesz, R., Dulak, J. & Dembinska-Kiec, A. (2000) Effect of linoleic acid on the expression of nitric oxide synthase and heme oxygenase-1 in rat vascular smooth muscle cells;in Advances in Lipoprotein and Atherosclerosis Research. Proc. 10th International Dresden Symposium on Lipoprotein and Atherosclerosis, in press.
52. Dulak, J., Jozkowicz, A., Foresti, R., Green, C. & Motterlini, R. (1999) Regulation of VEGF synthesis in vascular smooth muscle cells by carbon monoxide and nitric oxide metabolic pathways. Angiogenesis and Tumors, pp. 22-25, October 1999, Paris, France. Abstract.